The Trump administration is not backing down from its America First trade agenda, and Congress has granted the executive branch the authority to use emergency powers to impose tariffs in support of that agenda, U.S. Trade Representative Jamieson Greer told the Senate Finance Committee in a hearing on Tuesday.
CPA remains unwavering in our commitment to rebuilding U.S. industry and supporting American workers. China’s latest move only proves that our efforts are making an impact—and we will not back down.
The United States is amid a dangerous drug shortage that endangers patients, undermines our health care system and exposes a deep vulnerability to national security. America’s overwhelming reliance on foreign manufacturers for generic drugs is at the center of it.
On April 2, President Donald Trump took bold and historic action to defend American industry with the announcement of sweeping new tariffs aimed at countering unfair foreign trade practices and reigniting U.S. manufacturing. Dubbed “Liberation Day”, this policy marks the first major step in a new era of economic revitalization—one where the United States refuses to accept the systematic dismantling of its industrial base and begins to chart a path back to true production-led prosperity.
The Trump administration’s decision to impose a permanent 10% baseline tariff on imports from all countries, combined strategically with higher reciprocal tariffs on nations engaging in unfair trade practices, marks a crucial step forward in reindustrializing America and restoring economic strength and security.
Break out the Grizzly cooler and fire up the Broilmaster—it’s Liberation Day. In President Trump’s words, April 2 marks the end of the US of A being “ripped off by virtually every country in the world.”
The stock market is not the economy, and it certainly isn’t a proxy for the health of U.S. manufacturing or working-class prosperity.
The NTE report specifically identifies significant barriers and illicit trade practices, particularly involving China, impacting the solar, automotive, and steel industries, underscoring the urgent need for robust U.S. enforcement to address transshipment and tariff evasion.
The National Institutes of Health (NIH) is today the main source of new drugs in this country – indeed the world, because America leads in the field. It has a critical importance to America’s health. Less well known is its huge, positive, economic impact.
In June 2022, the Biden administration introduced a two-year tariff moratorium, temporarily suspending import duties on solar cells and panels from four key Southeast Asian exporting nations—Cambodia, Malaysia, Thailand, and Vietnam.
Notifications